Search results for: 'Preferred Destination for Early Phase Clinical Trials'
- Did you mean
- preferred desalination for earth paas clinical trials
- preferred desalination for earth phone clinical trials
- Related search terms
- forces managed security services market study
- clinical communications market research
- clinical environment market size ® invest 2025
- clinical environment market size ® invest 2030
- clinical environment market size ® invest 2020
-
19 Sep 2023  |  North America  |  Market Research
Growth Opportunities for Clinical Laboratory Services in Asia-Pacific
Proliferation of High-end Specialized Testing and Interconnected Lab Networks Fuel Growth Potential
Clinical labs are the foundation of the healthcare ecosystem. This research overviews the Asia-Pacific (APAC) clinical laboratory services industry for the period 2022–2028. Country-specific and vertical-specific forecasts are provided from 2023 to 2028 using a base year of 2022. Frost & Sullivan focused on APAC following various events unfolding f...
$4,950.00
Special Price $3,712.50 save 25 %
-
23 Apr 2025  |  North America  |  Frost Radar
Frost Radar™: Clinical Documentation Integrity in North America, 2025
A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines
As the healthcare industry shifts from a fee-for-service to a fee-for-value model, value-based reimbursement is becoming the standard for accountable care organizations (ACOs), independent physician practices, and non-ACO entities. This transition underscores the essential role of clinical documentation integrity (CDI) specialists, medical coders, ...
$4,950.00
Special Price $4,455.00 save 10 %
-
16 Aug 2021  |  North America  |  Market Research
Global Drug Discovery and Early Development Outsourcing Growth Opportunities
Growing Research and Development Pipelines of Emerging Biopharmaceutical and Niche Technology Providers Drive Competitive Intensity
Frost & Sullivan presents post-COVID-19 growth opportunities and strategic imperatives for the global drug discovery and early development outsourcing market in this study, which covers research and development (R&D) efforts, market trends, key participants, drivers and restraints of market adoption, and recent mergers and acquisitions. The report ...
$4,950.00
Special Price $3,712.50 save 25 %
-
08 Mar 2022  |  North America  |  Market Research
US Clinical Decision Support System (CDSS) Growth Opportunities
Sparking Future Growth Potential for Health Data, AI, and SDoH to Increase Accuracy and Efficiency among Providers and Payers and Improve the Patient Journey
Clinical decision support (CDS) is a broad concept with many definitions that are used variably, depending on the perspective and role of the expert. It includes a mix of evidence (content), analytics, workflow, devices, and software-based solutions that must include electronic health records (EHRs) and be maintained by an IT platform. This repo...
$4,950.00
Special Price $3,712.50 save 25 %
-
22 Apr 2025  |  North America  |  Frost Radar
Frost Radar™: Clinical Decision Support Systems in North America, 2025
A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines
This Frost Radar™ benchmarks the growth and innovation activity of clinical decision support system (CDSS) vendors in their effort to provide end users with evidence to take the next best action. The CDSS role is evolving from just being the source of clinical knowledge at the point of care or facilitating clinical decision-making and workflow. New...
$4,950.00
Special Price $4,455.00 save 10 %
-
15 Jul 2026  |  North America  |  Frost Radar
Frost Radar™: Clinical Ambient AI in North America, 2026
A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines
This Frost Radar™ analyzes the clinical ambient AI solutions that enable clinicians to improve their efficiency at the point of care. AI scribe capability has become the baseline market requirement, eliminating it as a differentiator and pushing vendors to compete on higher-order clinical and financial workflow integration. These capabilities inclu...
$4,950.00 -
24 Dec 2015  |  North America  |  Market Research
Global Clinical Next-generation Sequencing Market
Learn the Emerging Clinical Applications and Best Practices to the Road to Reimbursement
This market insight covers the challenges associated with the adoption of next-generation sequencing (NGS)-based testing for routine diagnostic use. Emerging applications for gene panel and whole exome sequencing are discussed. Best practices and guidance have been provided to attain coverage on newly launched tests through case study analysis. Tab...
$1,500.00
Special Price $1,125.00 save 25 %
-
22 Sep 2022  |  North America  |  Market Research
AI Commercial Use Cases, Impact Analyses, and Growth Opportunities in Clinical Genomics
Integration of Clinical Genomics and AI will lead to definitive Transformational Growth in the Next Decade
Clinical genomics regained significance during the pandemic with the development of the mRNA COVID-19 vaccine, and several non-invasive at-home test kits; an unprecedented feat in recent times. Genomics will take center stage, as large genome sequencing and research will continuously create data for new therapeutics. Artificial Intelligence (AI) an...
$2,450.00
Special Price $1,837.50 save 25 %
-
31 May 2022  |  North America  |  Market Research
Global RNA Therapeutics Growth Opportunities
Future Growth Potential Driven by Co-Development Programs and Robust Clinical Trials for Diverse Disease Areas
Scientific advancements in nucleic acid-based therapies have significantly impacted the global biopharmaceutical industry. The ribonucleic acid (RNA) therapeutics market is expected to witness remarkable clinical progress as therapies target “undruggable” pathways. Technologically advanced platforms are integrated into RNA therapeutics bioprocessin...
$2,450.00
Special Price $1,837.50 save 25 %
-
30 Mar 2019  |  North America  |  Technology Research
Breakthroughs in Non-Alcoholic Steatohepatitis Management
Multiple Investigational New Drugs with high potential for better treatment outcomes progressing through critical stages of clinical development
Non-Alcoholic Steatohepatitis or NASH is a liver disorder that is characterized by the build-up of fat in liver in addition to inflammation and liver cell damage eventually progressing to cirrhosis. Currently lifestyle interventions are suggested for the treatment of NASH with no drugs having been approved for the condition. Multiple drugs are at ...
$4,950.00
Special Price $3,712.50 save 25 %